Skip to main content
. Author manuscript; available in PMC: 2021 Nov 17.
Published in final edited form as: Am J Ophthalmol. 2020 May 22;219:87–100. doi: 10.1016/j.ajo.2020.05.024

Table 5.

Mean and Adjusted Mean Full Field Hill of Vision (VTOT)

Models N=126a Mean (SD) – decibel steradians Adjusted Mean (95% CI)- decibel steradiansb Difference from Reference Group (95% CI) P-valuec
Clinical Diagnosis <0.001
 USH2 80 22.5 (21.5) 22.9 (17.9, 28.0) Reference
 ARRP 46 37.1 (24.7) 36.3 (29.5, 43.1) 13.4 (4.2, 22.6)
Duration of disease, yrs d <0.001
 <10 36 40.5 (22.6) 39.1 (31.9, 46.3) Reference
 [10,20) 46 28.5 (21.9) 27.9 (21.7, 34.0) −11.2 (−20.3, −2.1)
 >=20 43 15.0 (18.2) 21.9 (13.8, 30.1) −17.2 (−28.9, −5.4)
Age of enrollment, yrs e 0.02
 <35 44 35.7 (23.0) 35.4 (27.1, 43.6) Reference
 35–45 43 23.9 (22.4) 27.7 (21.3, 34.1) −7.6 (−18.4, 3.1)
 >=45 39 23.1 (24.2) 25.8 (18.8, 32.7) −9.6 (−21.4, 2.2)
a

Static perimetry results were graded by a reading center. Results are based on the average of 3 fields when 3 tests were performed (primary cohort); otherwise they based on just the 1 test performed (secondary cohort). Static perimetry data is not included for 1 participant in the ARRP group (participant was not tested).

b

Simultaneous adjustment for duration of disease, clinical diagnosis, and age of enrollment

c

Factors are presented categorically to show the data but were analyzed using continuous version of the factor in the model.

d

1 participant in the ARRP group was missing age of onset (a participant-reported field based on their awareness of visual symptoms) and duration of disease (computed based on age of onset and date of enrollment)

e

28 participants were not permitted to report date of birth due to regulatory restrictions. Therefore, only year of birth and categorical age was reported. For those participants, July 1st with the reported birth year was imputed as birth date to calculate continuous age